Risk Factors Update Summary
- Increased scrutiny on personal data transfers under GDPR and DPF, with potential legal challenges.
- Added risks related to raising additional capital causing dilution, with accumulated deficit increasing from $358 million to $570 million.
- Fines under GDPR and UK GDPR mirror each other, with fines up to €[value] million or 4% of global turnover.
- Increased focus on potential delays, costs, and limitations due to ongoing and planned clinical trials.
- The UK Extension to the DPF came into effect, providing a data transfer mechanism.
- Introduction of risks related to unstable market conditions and adverse developments affecting financial institutions.
- Legal complexity and uncertainty in international data transfers may lead to increased costs.
- Enhanced cybersecurity risks due to continued hybrid working environment and remote work.
- Potential disruptions from unauthorized disclosure of proprietary or sensitive information, impacting business operations.
- Market and economic instability risks from geopolitical events, sanctions, and financial market closures.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1599901&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.